Annual Operating Expenses
$131.63 M
-$5.64 M-4.11%
December 31, 2024
Summary
- As of March 6, 2025, CTKB annual total operating expenses is $131.63 million, with the most recent change of -$5.64 million (-4.11%) on December 31, 2024.
- During the last 3 years, CTKB annual operating expenses has risen by +$61.64 million (+88.08%).
- CTKB annual operating expenses is now -4.11% below its all-time high of $137.27 million, reached on December 31, 2023.
Performance
CTKB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$30.67 M
-$2.59 M-7.78%
December 31, 2024
Summary
- As of March 6, 2025, CTKB quarterly total operating expenses is $30.67 million, with the most recent change of -$2.59 million (-7.78%) on December 31, 2024.
- Over the past year, CTKB quarterly operating expenses has stayed the same.
- CTKB quarterly operating expenses is now -17.76% below its all-time high of $37.29 million, reached on June 30, 2023.
Performance
CTKB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CTKB Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -4.1% | 0.0% |
3 y3 years | +88.1% | -17.8% |
5 y5 years | +408.0% | -17.8% |
CTKB Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -4.1% | +88.1% | -17.8% | +37.4% |
5 y | 5-year | -4.1% | +408.0% | -17.8% | +261.3% |
alltime | all time | -4.1% | +408.0% | -17.8% | +261.3% |
Cytek Biosciences Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $131.63 M(-4.1%) | $30.67 M(-7.8%) |
Sep 2024 | - | $33.25 M(-2.1%) |
Jun 2024 | - | $33.96 M(+0.6%) |
Mar 2024 | - | $33.75 M(+1.7%) |
Dec 2023 | $137.27 M(+33.6%) | $33.19 M(-1.2%) |
Sep 2023 | - | $33.60 M(-9.9%) |
Jun 2023 | - | $37.29 M(+12.3%) |
Mar 2023 | - | $33.20 M(+13.3%) |
Dec 2022 | $102.78 M | $29.29 M(+14.9%) |
Sep 2022 | - | $25.50 M(+0.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $25.45 M(+12.9%) |
Mar 2022 | - | $22.53 M(+1.0%) |
Dec 2021 | $69.99 M(+83.9%) | $22.32 M(+21.4%) |
Sep 2021 | - | $18.38 M(+15.4%) |
Jun 2021 | - | $15.93 M(+19.3%) |
Mar 2021 | - | $13.35 M(+15.4%) |
Dec 2020 | $38.05 M(+46.9%) | $11.57 M(+30.0%) |
Sep 2020 | - | $8.90 M(+4.9%) |
Jun 2020 | - | $8.49 M(-6.6%) |
Mar 2020 | - | $9.09 M |
Dec 2019 | $25.91 M | - |
FAQ
- What is Cytek Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Cytek Biosciences?
- What is Cytek Biosciences annual operating expenses year-on-year change?
- What is Cytek Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cytek Biosciences?
- What is Cytek Biosciences quarterly operating expenses year-on-year change?
What is Cytek Biosciences annual total operating expenses?
The current annual operating expenses of CTKB is $131.63 M
What is the all time high annual operating expenses for Cytek Biosciences?
Cytek Biosciences all-time high annual total operating expenses is $137.27 M
What is Cytek Biosciences annual operating expenses year-on-year change?
Over the past year, CTKB annual total operating expenses has changed by -$5.64 M (-4.11%)
What is Cytek Biosciences quarterly total operating expenses?
The current quarterly operating expenses of CTKB is $30.67 M
What is the all time high quarterly operating expenses for Cytek Biosciences?
Cytek Biosciences all-time high quarterly total operating expenses is $37.29 M
What is Cytek Biosciences quarterly operating expenses year-on-year change?
Over the past year, CTKB quarterly total operating expenses has changed by $0.00 (0.00%)